Moleculin Biotech
MBRX
MBRX
29 hedge funds and large institutions have $8.88M invested in Moleculin Biotech in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.93M | |
| 2 | +$1.51M | |
| 3 | +$947K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$513K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$146K |
Top Sellers
| 1 | -$756K | |
| 2 | -$105K | |
| 3 | -$29K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$21K |
| 5 |
LWMG
Levy Wealth Management Group
Philadelphia,
Pennsylvania
|
-$11K |